Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 2
1988 1
1989 1
1990 2
1991 2
1992 2
1993 1
1995 1
1996 1
1998 6
1999 4
2000 2
2001 1
2002 3
2003 2
2004 2
2006 6
2007 5
2008 2
2009 1
2010 7
2011 10
2012 8
2013 13
2014 11
2015 6
2016 8
2017 9
2018 16
2019 18
2020 13
2021 8
2022 11
2023 11
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Low Grade Lung Neuroendocrine Neoplasm"
Page 1
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME, Baudin E, Ferolla P, Filosso P, Garcia-Yuste M, Lim E, Oberg K, Pelosi G, Perren A, Rossi RE, Travis WD; ENETS consensus conference participants. Caplin ME, et al. Ann Oncol. 2015 Aug;26(8):1604-20. doi: 10.1093/annonc/mdv041. Epub 2015 Feb 2. Ann Oncol. 2015. PMID: 25646366 Free article. Review.
PATIENTS AND METHODS: Bibliographical searches were carried out in PubMed for the terms 'pulmonary neuroendocrine tumors', 'bronchial neuroendocrine tumors', 'bronchial carcinoid tumors', 'pulmonary carcinoid', 'pulmonary typical/atypical carcin …
PATIENTS AND METHODS: Bibliographical searches were carried out in PubMed for the terms 'pulmonary neuroendocrine tumors', 'br …
A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors.
Patel SP, Othus M, Chae YK, Giles FJ, Hansel DE, Singh PP, Fontaine A, Shah MH, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, McLeod C, Chen HX, Sharon E, Mayerson E, Ryan CW, Plets M, Blanke CD, Kurzrock R. Patel SP, et al. Clin Cancer Res. 2020 May 15;26(10):2290-2296. doi: 10.1158/1078-0432.CCR-19-3356. Epub 2020 Jan 22. Clin Cancer Res. 2020. PMID: 31969335 Free PMC article. Clinical Trial.
PURPOSE: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare tumors. We report the results of the (nonpancreatic) neuroendocrine neoplasm cohort of SWOG S1609 dual anti-CTLA-4 and ant …
PURPOSE: Immune checkpoint blockade has improved outcomes across tumor types; little is known about the efficacy of these agents in rare …
Therapeutic options in lung neuroendocrine tumors: between established concepts and new hopes.
Brighi N, Lamberti G, Manuzzi L, Maggio I, Campana D. Brighi N, et al. Anticancer Drugs. 2019 Aug;30(7):e0784. doi: 10.1097/CAD.0000000000000784. Anticancer Drugs. 2019. PMID: 30896503 Review.
Typical (TC) and atypical (AC) carcinoids are low-grade neuroendocrine tumors (NETs) of the lung and, are neglected diseases in respect of both high-grade NETs of the lung (i.e. small-cell lung cancer and large-cell neuro …
Typical (TC) and atypical (AC) carcinoids are low-grade neuroendocrine tumors (NETs) of the lung and, are …
Molecular alterations of neuroendocrine tumours of the lung.
Rossi G, Bertero L, Marchiò C, Papotti M. Rossi G, et al. Histopathology. 2018 Jan;72(1):142-152. doi: 10.1111/his.13394. Histopathology. 2018. PMID: 29239031 Review.
Neuroendocrine tumours of the lung comprise low [typical carcinoid (TC)], intermediate [atypical carcinoid (AC)] and high-grade [small-cell lung cancer (SCLC) and large-cell neuroendocrine carcinoma (LCNEC)] malignancies, while a pre-inva …
Neuroendocrine tumours of the lung comprise low [typical carcinoid (TC)], intermediate [atypical carcinoid (AC)] and hi …
Classification of lung neuroendocrine tumors: lights and shadows.
Volante M, Gatti G, Papotti M. Volante M, et al. Endocrine. 2015 Nov;50(2):315-9. doi: 10.1007/s12020-015-0578-x. Epub 2015 Mar 21. Endocrine. 2015. PMID: 25795289 Review.
Neuroendocrine tumors of the lung are classified into low-grade typical and intermediate-grade atypical carcinoids, and high-grade poorly differentiated neuroendocrine carcinomas of the large and small cell types. ...Moreove …
Neuroendocrine tumors of the lung are classified into low-grade typical and intermediate-grade aty …
Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.
Pelosi G, Papotti M, Rindi G, Scarpa A. Pelosi G, et al. Endocr Pathol. 2014 Jun;25(2):151-64. doi: 10.1007/s12022-014-9320-0. Endocr Pathol. 2014. PMID: 24771462 Review.
Currently, grading in lung neuroendocrine tumors (NETs) is inherently defined by the histological classification based on cell features, mitosis count, and necrosis, for which typical carcinoids (TC) are low-grade malignant tumors …
Currently, grading in lung neuroendocrine tumors (NETs) is inherently defined by the histological classification …
Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors.
Cameselle-Teijeiro JM, Mato Mato JA, Fernández Calvo O, García Mata J. Cameselle-Teijeiro JM, et al. Mol Diagn Ther. 2018 Apr;22(2):169-177. doi: 10.1007/s40291-018-0315-2. Mol Diagn Ther. 2018. PMID: 29427124 Review.
Neuroendocrine tumors (NETs) belong to a heterogeneous family of rare tumors with very broad and complex clinical behavior. ...This paper provides a review of the current histopathological diagnostic approaches for lung NET subtypes, including the p …
Neuroendocrine tumors (NETs) belong to a heterogeneous family of rare tumors with very broad and complex clinical behav …
Neuroendocrine breast carcinoma: a rare but challenging entity.
Trevisi E, La Salvia A, Daniele L, Brizzi MP, De Rosa G, Scagliotti GV, Di Maio M. Trevisi E, et al. Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4. Med Oncol. 2020. PMID: 32712767 Free PMC article. Review.
Breast carcinoma with neuroendocrine differentiation, also known as neuroendocrine breast carcinoma (NEBC), includes a heterogeneous group of rare tumors, which account for 2-5% of all invasive breast carcinomas. Because of their low incidence, most of …
Breast carcinoma with neuroendocrine differentiation, also known as neuroendocrine breast carcinoma (NEBC), includes a heterog …
Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.
Thomas KEH, Voros BA, Boudreaux JP, Thiagarajan R, Woltering EA, Ramirez RA. Thomas KEH, et al. Oncologist. 2019 Aug;24(8):1076-1088. doi: 10.1634/theoncologist.2018-0604. Epub 2019 Jan 11. Oncologist. 2019. PMID: 30635447 Free PMC article. Review.
Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas (GEPNECs) are a rare neoplasm with a bleak prognosis. ...Food and Drug Administration approval of peptide receptor radionuclide therapy in low- and intermediate-grade neur …
Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas (GEPNECs) are a rare neoplasm with a bleak prognosis …
Lung carcinoid tumours: histology and Ki-67, the eternal rivalry.
Centonze G, Maisonneuve P, Simbolo M, Lagano V, Grillo F, Fabbri A, Prinzi N, Garzone G, Filugelli M, Pardo C, Mietta A, Pusceddu S, Sabella G, Bercich L, Mangogna A, Rolli L, Grisanti S, Benvenuti MR, Pastorino U, Roz L, Scarpa A, Berruti A, Capella C, Milione M. Centonze G, et al. Histopathology. 2023 Jan;82(2):324-339. doi: 10.1111/his.14819. Epub 2022 Oct 26. Histopathology. 2023. PMID: 36239545 Free PMC article.
WHO classification of Thoracic Tumours defines lung carcinoid tumours (LCTs) as well-differentiated neuroendocrine neoplasms (NENs) classified in low grade typical (TC) and intermediate grade atypical carcinoids (AC). ...Ki-67 3% plays a potenti …
WHO classification of Thoracic Tumours defines lung carcinoid tumours (LCTs) as well-differentiated neuroendocrine neoplasms ( …
173 results